Among the many tumors in which CAIX was expressed are head and neck cancers [16], breast cancers [54–60], esophageal cancers [61, 62], pancreatic cancers [63–65], and soft tissue tumors [66, 67], whose worse prognosis was associated with the presence of CAIX. Here, CA9 is linked to pancreatic neoplasm.